David E. Joyce

2.7k total citations · 1 hit paper
20 papers, 2.0k citations indexed

About

David E. Joyce is a scholar working on Epidemiology, Hematology and Molecular Biology. According to data from OpenAlex, David E. Joyce has authored 20 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 8 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in David E. Joyce's work include Sepsis Diagnosis and Treatment (12 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers) and Cardiac Structural Anomalies and Repair (2 papers). David E. Joyce is often cited by papers focused on Sepsis Diagnosis and Treatment (12 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers) and Cardiac Structural Anomalies and Repair (2 papers). David E. Joyce collaborates with scholars based in United States, Australia and Netherlands. David E. Joyce's co-authors include Brian W. Grinnell, A Ciaccia, Boumediene Bouzahzah, Min Fu, James H. Steer, S. Betty Yan, John T. Brandt, Bruce R. Basson, David R. Nelson and Marcel Levi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

David E. Joyce

18 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis

2001 535 citations David E. Joyce, A Ciaccia et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David E. Joyce United States	13	809	741	386	334	277	20	2.0k
A. Sturk Netherlands	16	540 0.7×	442 0.6×	413 1.1×	516 1.5×	137 0.5×	35	1.9k
Claudia Marsik Austria	25	539 0.7×	291 0.4×	419 1.1×	394 1.2×	102 0.4×	53	1.9k
N. Semeraro Italy	29	629 0.8×	1.5k 2.0×	538 1.4×	534 1.6×	175 0.6×	142	3.5k
Teresa Paglieroni United States	29	264 0.3×	978 1.3×	346 0.9×	334 1.0×	331 1.2×	60	2.8k
Nils U. Bang United States	30	323 0.4×	1.2k 1.6×	387 1.0×	230 0.7×	79 0.3×	90	2.6k
Arie J. Hoogendijk Netherlands	23	778 1.0×	207 0.3×	480 1.2×	637 1.9×	256 0.9×	76	2.0k
G. Myllylä Finland	30	305 0.4×	1.1k 1.5×	415 1.1×	410 1.2×	693 2.5×	98	3.0k
Franco Manzato Italy	24	364 0.4×	939 1.3×	200 0.5×	90 0.3×	41 0.1×	57	1.9k
Mark Roest Netherlands	25	170 0.2×	555 0.7×	240 0.6×	180 0.5×	33 0.1×	65	1.9k
Lona Poole United States	7	496 0.6×	428 0.6×	207 0.5×	358 1.1×	168 0.6×	13	1.4k

Countries citing papers authored by David E. Joyce

Since Specialization

Citations

This map shows the geographic impact of David E. Joyce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Joyce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Joyce more than expected).

Fields of papers citing papers by David E. Joyce

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Joyce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Joyce. The network helps show where David E. Joyce may publish in the future.

Co-authorship network of co-authors of David E. Joyce

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Joyce. A scholar is included among the top collaborators of David E. Joyce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Joyce. David E. Joyce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Joyce, David E., et al.. (2006). Evaluation of the thrombospondin-1 analogue ABT-510 in the APC^Min/+ mouse intestinal adenoma model. Journal of Clinical Oncology. 24(18_suppl). 13545–13545. 2 indexed citations

Schneider, Nicole M., et al.. (2005). Rupture of Inlet Graft of the HeartMate System: A Case Report. The Journal of Heart and Lung Transplantation. 25(1). 137–139. 1 indexed citations

Joyce, David E., David R. Nelson, & Brian W. Grinnell. (2004). Leukocyte and endothelial cell interactions in sepsis: Relevance of the protein C pathway. Critical Care Medicine. 32(Supplement). S280–S286. 145 indexed citations

Dhainaut, J. F., S. Betty Yan, David E. Joyce, et al.. (2004). Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. Journal of Thrombosis and Haemostasis. 2(11). 1924–1933. 302 indexed citations

Joyce, David E., Jacques Leclerc, David R. Nelson, Howard Levy, & Rakesh Garg. (2004). Outcomes of cancer patients treated with drotrecogin alfa (activated) for severe sepsis. Journal of Clinical Oncology. 22(14_suppl). 6055–6055. 1 indexed citations

Joyce, David E., Jacinthe Leclerc, David R. Nelson, Howard Levy, & Rakesh Garg. (2004). Outcomes of cancer patients treated with drotrecogin alfa (activated) for severe sepsis. Journal of Clinical Oncology. 22(14_suppl). 6055–6055. 1 indexed citations

Bernard, Gordon R., et al.. (2003). Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis. Critical Care. 7(2). 155–63. 87 indexed citations

Wunderink, Richard G., Sachin Yende, Pierre‐François Laterre, et al.. (2003). Drotrecogin Alfa (activated) Improves In-hospital and 90-day Survival in Patients With Severe Sepsis and Community-acquired Pneumoni. CHEST Journal. 124(4). 91S–91S. 182 indexed citations

Kerlin, Bryce A., S. Betty Yan, Berend Isermann, et al.. (2003). Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia. Blood. 102(9). 3085–3092. 125 indexed citations

10.

Joyce, David E., et al.. (2002). Human Recombinant Activated Protein C in Meningococcal Sepsis. CHEST Journal. 121(1). 292–295. 19 indexed citations

11.

Joyce, David E. & Brian W. Grinnell. (2002). Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-κB. Critical Care Medicine. 30(Supplement). S288–S293. 164 indexed citations

12.

Joyce, David E.. (2002). The contribution of prothrombotic states to cancer-related stroke. 2(2). 151–158. 1 indexed citations

13.

Joyce, David E., et al.. (2001). NF-κB and cell-cycle regulation: the cyclin connection. Cytokine & Growth Factor Reviews. 12(1). 73–90. 331 indexed citations

14.

Joyce, David E., et al.. (2001). Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis. Journal of Biological Chemistry. 276(14). 11199–11203. 535 indexed citations breakdown →

15.

Grinnell, Brian W. & David E. Joyce. (2001). Recombinant human activated protein C: A system modulator of vascular function for treatment of severe sepsis. Critical Care Medicine. 29(7 Suppl). S53–S60. 72 indexed citations

16.

Joyce, David E., Bo‐Shiun Yan, Bruce R. Basson, & Jean François Dhainaut. (2001). Disseminated intravascular coagulation in severe sepsis patients treated with recombinant human Activated Protein C, a retrospective subgroup analysis from the PROWESS trial. 1. 44516. 2 indexed citations

17.

Richardson, Mark A., David T. Berg, David S. Calnek, et al.. (2000). 17β-Estradiol, But Not Raloxifene, Decreases Thrombomodulin in the Antithrombotic Protein C Pathway. Endocrinology. 141(10). 3908–3911. 16 indexed citations

18.

Joyce, David E., et al.. (1997). Functional Interactions Between the Thrombin Receptor and the T-Cell Antigen Receptor in Human T-Cell Lines. Blood. 90(5). 1893–1901. 23 indexed citations

19.

Fernández, Javier, David E. Joyce, S. Steven Yang, et al.. (1993). Valve-related events and valve-related mortality in 340 mitral valve repairs *1A late phase follow-up study. European Journal of Cardio-Thoracic Surgery. 7(5). 263–270. 7 indexed citations

20.

Joyce, David E.. (1989). d-penicillamine pharmacokinetics and pharmacodynamics in man. Pharmacology & Therapeutics. 42(3). 405–427. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact